acalabrutinib (ACP-196)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for acalabrutinib (ACP-196), covering 2018-10-19 to 2018-10-19. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma [Phase 2]